INmune Bio, Inc.INMBNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-42.08M
↓ 750% below average
Average (9y)
$-4.95M
Historical baseline
Range
High:$149990.00
Low:$-42.08M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-42.08M | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | +100.0% |
| 2019 | $-7.68M | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $149990.00 | +400.0% |
| 2016 | $-50000.00 | -134.1% |
| 2015 | $146604.00 | - |